Drug giant Eli Lilly bought an emerging Peninsula skin drug company last year — here’s what’s left of it

A blockbuster atopic dermatitis drug is moving closer to an FDA decision, another is rolling up into an Arizona company, another Bay Area company is launching, a Peninsula site is closing and 163 jobs are getting cut.